Alibion AG

https://www.alibion.com

Alibion is a pre-clinical stage drug-development company developing the first personalized therapy against Rheumatoid arthritis. *

	Start	2019-01-01 existent
	Industry	antirheumatic
	Industry 2	personalised medicine / precision medicine

	Region	Allschwil BL
	Country	Switzerland
	Street	24 Gewerbestr. Switzerland Innovation Park Basel Area AG
	City	4123 Allschwil BL
	Tel	+41-79-549-0242
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: BaseLaunch (BaselArea.swiss). (10/3/19). "Press Release: 15 Companies Chosen for Phase 1". Basel.

		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Alibion AG

[1] BaseLaunch (BaselArea.swiss). (10/3/19). "Press Release: 15 Companies Chosen for Phase 1". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]